Total submissions: 9
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000908809 | SCV001053589 | likely benign | not provided | 2024-09-11 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000908809 | SCV001844152 | benign | not provided | 2021-05-10 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002540782 | SCV003582142 | likely benign | Inborn genetic diseases | 2021-05-24 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Ce |
RCV000908809 | SCV004140839 | likely benign | not provided | 2024-09-01 | criteria provided, single submitter | clinical testing | CACNA1G: BS1 |
Breakthrough Genomics, |
RCV000908809 | SCV005218151 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Laboratory of Diagnostic Genome Analysis, |
RCV000908809 | SCV001798873 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV000908809 | SCV001929897 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000908809 | SCV001970421 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Prevention |
RCV004541930 | SCV004775972 | likely benign | CACNA1G-related disorder | 2023-02-13 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |